Last updated: January 29, 2024
Sponsor: University of Salamanca
Overall Status: Active - Recruiting
Phase
N/A
Condition
Cerebral Ischemia
Stroke
Treatment
Action Observation (AO)
Motor Imagery (MI)
Control condition- placebo
Clinical Study ID
NCT06230718
MIAO
Ages 18-99 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Being over 18 years of age
- Diagnoses of established stroke
- Present limitations or motor response deficiencies in the upper limb
- Maintain cognitive functions with the ability to follow the instructions of theinterventions and evaluations (MOCA>14)
Exclusion
Exclusion Criteria:
- Diagnosed with mental illness before the stroke
- Other systemic conditions on the central nervous system
- Cardiorespiratory system pathologies in severe cases
- Acute period, fever, muscle inflammation or myopathies
- Any type of vascular and organic insufficiency
- Liver disease or skin lesions in the area of application of the electrodes.
Study Design
Total Participants: 28
Treatment Group(s): 3
Primary Treatment: Action Observation (AO)
Phase:
Study Start date:
January 01, 2024
Estimated Completion Date:
January 30, 2025
Study Description
Connect with a study center
Universidad de Salmanca
Salamanca, 37007
SpainActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.